Stockrabit · Analysts
Questions across 1 call

Vikas Sharda

NTAsset Management

Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Limited CC-Mar24.pdf · 2024-05-27
Two questions. With receivables is down sharply this quarter , could you explain I mean is it because of the provisions for rebates that you have made or how should one look at it? And also what is the nature of this provision that we made , I mean what was the need of making this provision and how should one look at that?
So, this like 1,100 plus crores of reduction in the debtors, so 600 crores is because of India and what would be the remaining 500 crores for?